X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Agentic AI in Pharma Transforming RD to Commercialisation

    Agentic AI in Pharma: Transforming R&D to Commercialisation

    New Software to Predict Cell Activity for Cancer Research

    New Software to Predict Cell Activity for Cancer Research

    Biosimulation Market Size

    Biosimulation Market Size and Growth Projections: 2025–2030

    The Future of Clinical

    The Future of Clinical Trial Data in Decentralisation Models

    GSK and Hengrui Pharma

    GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

    Aptar Pharma Bolsters Clinical Trial.

    Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Agentic AI in Pharma Transforming RD to Commercialisation

    Agentic AI in Pharma: Transforming R&D to Commercialisation

    New Software to Predict Cell Activity for Cancer Research

    New Software to Predict Cell Activity for Cancer Research

    Biosimulation Market Size

    Biosimulation Market Size and Growth Projections: 2025–2030

    The Future of Clinical

    The Future of Clinical Trial Data in Decentralisation Models

    GSK and Hengrui Pharma

    GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

    Aptar Pharma Bolsters Clinical Trial.

    Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Clinical Trials

New Analysis Supports Medisafe’s Impact on Medication Persistence, Adherence

Content Team by Content Team
9th July 2021
in Clinical Trials, Drug Development, News
New Analysis Supports Medisafe's Impact on Medication Persistence, Adherence

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Previous Post

Cellenkos Selects Cryoport to Support On-Demand, Flexible COVID-19 Therapy Shipments to Patients in Need

Next Post

Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using Fugaku

Related Posts

Agentic AI in Pharma Transforming RD to Commercialisation
Clinical Trials

Agentic AI in Pharma: Transforming R&D to Commercialisation

31st July 2025
New Software to Predict Cell Activity for Cancer Research
News

New Software to Predict Cell Activity for Cancer Research

30th July 2025
Biosimulation Market Size
Drug Development

Biosimulation Market Size and Growth Projections: 2025–2030

30th July 2025
The Future of Clinical
Clinical Trials

The Future of Clinical Trial Data in Decentralisation Models

30th July 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Next Post
Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using Fugaku

Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using Fugaku

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In